PSMC3IP as a prognostic biomarker and immunomodulatory regulator in low-grade glioma: insights from multi-omics and methylation analysis
Year: 2025
Type: article
Source: Neurological Research
Institutions: Zhengzhou University, Zhengzhou People's Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4412499672
